Depression with atypical neurovegetative symptoms shares genetic predisposition with immuno-metabolic traits and alcohol consumption
Isabella BadiniiD, Jonathan R.I. ColemaniD, Saskia P. HagenaarsiD, Matthew H. HotopfiD, Gerome D. BreeniD, Cathryn M. LewisiD, Chiara FabbriiD
Abstract
BackgroundDepression is a highly prevalent and heterogenous disorder. This study aims to determine whether depression with atypical features shows different heritability and different degree of overlap with polygenic risk for psychiatric and immuno-metabolic traits than other depression subgroups. MethodsData included 30,069 European ancestry individuals from the UK Biobank who met criteria for lifetime major depression. Participants reporting both weight gain and hypersomnia were classified as {uparrow}WS depression (N = 1,854) and the others as non-{uparrow}WS depression (N = 28,215). Cases with non-{uparrow}WS depression were further classified as {downarrow}WS depression (i.e. weight loss and insomnia; N = 10,142). Polygenic risk scores (PRS) for 22 traits were generated using genome-wide summary statistics (Bonferroni corrected p=2.1x10-4). Single nucleotide polymorphism (SNP)-based heritability of depression subgroups was estimated. Results{uparrow}WS depression had a higher polygenic risk for BMI (OR=1.20, [1.15-1.26], p=2.37e-14) and C-reactive protein (OR=1.11, [1.06-1.17], p=8.86e-06) vs. non-{uparrow}WS depression and {uparrow}WS depression. Leptin PRS was close to the significance threshold (p=2.99e-04), but the effect disappeared when considering GWAS summary statistics of leptin adjusted for BMI. PRS for daily alcohol use was inversely associated with {uparrow}WS depression (OR=0.88, [0.83-0.93], p=1.04e-05) vs. non-{uparrow}WS depression. SNP-based heritability was not significantly different between {uparrow}WS depression and {downarrow}WS depression (14.3% and 12.2%, respectively). Conclusions{uparrow}WS depression shows evidence of distinct genetic predisposition to immune-metabolic traits and alcohol consumption. These genetic signals suggest that biological targets including immune-cardiometabolic pathways may be relevant to therapies in individuals with {uparrow}WS depression.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 75
- FWCI
- 5.85
- Field percentile
- top 3%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Differential associations of various depression-related phenotypes with cardiometabolic risks: Identification of shared genetic factors and implications for drug repositioning
Brian Chi‐Fung Wong, Carlos Kwan‐Long Chau, … Hon‐Cheong So·bioRxiv·Aug 23, 2017
- Characterisation and Genetic Architecture of Major Depressive Disorder Subgroups Defined by Weight and Sleep Changes
Sally Marshall, Mark J. Adams, … Pippa A. Thomson·bioRxiv·Aug 30, 2022
- Genetic comorbidity between major depression and cardio-metabolic disease, stratified by age at onset of major depression.
Saskia P. Hagenaars, JRI Coleman, … Cathryn M. Lewis·bioRxiv·May 24, 2019
- A phenome-wide association and Mendelian Randomisation study of polygenic risk for depression in UK Biobank
Xueyi Shen, David M. Howard, … Michael John Owen·Nature CommunicationsPeer-reviewed·May 8, 2020
- Stratifying depression by neuroticism: revisiting a diagnostic tradition using GWAS data
Mark J. Adams, David M. Howard, … Andrew Mark McIntosh·bioRxiv·Feb 20, 2019
- Genetic heterogeneity in depressive symptoms following the death of a spouse: Polygenic score analysis of the US Health and Retirement Study
Ben W Domingue, Hexuan Liu, … Daniel W. Belsky·American Journal of PsychiatryPeer-reviewed·Oct 1, 2017